Warm Springs Advisors Inc. acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 481 shares of the healthcare conglomerate’s stock, valued at approximately $243,000.
Other large investors have also recently made changes to their positions in the company. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at about $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $26,000. Hurley Capital LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at $28,000. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group during the fourth quarter worth $30,000. Finally, Aster Capital Management DIFC Ltd acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $30,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several equities research analysts recently issued reports on the company. Royal Bank of Canada lowered their price objective on UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating on the stock in a report on Friday, May 16th. Hsbc Global Res cut UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a research report on Wednesday. Truist Financial reaffirmed a “buy” rating and set a $360.00 target price (down previously from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Wolfe Research decreased their price target on shares of UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating on the stock in a research note on Tuesday. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating for the company in a report on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $441.87.
Insider Buying and Selling
In other UnitedHealth Group news, Director Kristen Gil bought 3,700 shares of the company’s stock in a transaction that occurred on Thursday, May 15th. The shares were purchased at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the acquisition, the director now directly owns 3,818 shares of the company’s stock, valued at $1,035,327.06. This represents a 3,135.59% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the stock in a transaction dated Wednesday, May 14th. The shares were acquired at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the transaction, the director now owns 6,033 shares in the company, valued at approximately $1,935,386.40. This represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders purchased 109,408 shares of company stock valued at $31,607,768 in the last three months. 0.33% of the stock is owned by corporate insiders.
UnitedHealth Group Stock Down 0.4%
Shares of NYSE UNH opened at $295.37 on Friday. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73. The business’s 50 day moving average is $452.40 and its two-hundred day moving average is $505.07. The firm has a market cap of $267.94 billion, a price-to-earnings ratio of 19.06, a PEG ratio of 1.37 and a beta of 0.56. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period in the prior year, the firm earned $6.91 earnings per share. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.84%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 35.18%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- Stock Analyst Ratings and Canadian Analyst Ratings
- Pfizer’s 7.5% Dividend: Income Haven or House of Cards?
- How to Plot Fibonacci Price Inflection Levels
- 3 Trades Members of Congress Are Making Right Now
- How to Read Stock Charts for Beginners
- TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.